89 related articles for article (PubMed ID: 23246673)
1. Improvement of exercise capacity in monocrotaline-induced pulmonary hypertension by the phosphodiesterase-5 inhibitor Vardenafil.
Schroll S; Sebah D; Wagner M; Popara V; Pfeifer M; Blumberg F
Respir Physiol Neurobiol; 2013 Mar; 186(1):61-4. PubMed ID: 23246673
[TBL] [Abstract][Full Text] [Related]
2. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
3. The phosphodiesterase-5 inhibitor vardenafil reduces oxidative stress while reversing pulmonary arterial hypertension.
Fan YF; Zhang R; Jiang X; Wen L; Wu DC; Liu D; Yuan P; Wang YL; Jing ZC
Cardiovasc Res; 2013 Aug; 99(3):395-403. PubMed ID: 23650288
[TBL] [Abstract][Full Text] [Related]
4. Rosuvastatin, sildenafil and their combination in monocrotaline-induced pulmonary hypertension in rat.
Jasińska-Stroschein M; Owczarek J; Wesołowska A; Orszulak-Michalak D
Acta Pharm; 2014 Sep; 64(3):345-53. PubMed ID: 25296680
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
6. Additive effect of tadalafil and simvastatin on monocrotaline-induced pulmonary hypertension rats.
Zhang WH; Liu CP; Zhang YJ; Ji YQ; Lu WX; Zeng Q
Scand Cardiovasc J; 2012 Dec; 46(6):374-80. PubMed ID: 22971207
[TBL] [Abstract][Full Text] [Related]
7. The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.
Zeng Z; Li Y; Jiang Z; Wang C; Li B; Jiang W
Cardiovasc Ther; 2010; 28(1):23-9. PubMed ID: 20074256
[TBL] [Abstract][Full Text] [Related]
8. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of olmesartan medoxomil in the rat monocrotaline model of pulmonary hypertension.
Kato T; Nasu T; Sonoda H; Ito KM; Ikeda M; Ito K
J Cardiovasc Pharmacol; 2008 Jan; 51(1):18-23. PubMed ID: 18209564
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with fasudil and sildenafil ameliorates monocrotaline-induced pulmonary hypertension and survival in rats.
Elias-Al-Mamun M; Satoh K; Tanaka S; Shimizu T; Nergui S; Miyata S; Fukumoto Y; Shimokawa H
Circ J; 2014; 78(4):967-76. PubMed ID: 24553194
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary hemodynamic response to acute combination and monotherapy with sildenafil and brain natriuretic peptide in rats with monocrotaline-induced pulmonary hypertension.
Carlino C; Tobias JD; Schneider RI; Heller RL; Alpert MA; Grueber RE; Dellsperger KC; Demarco VG
Am J Med Sci; 2010 Jan; 339(1):55-9. PubMed ID: 19996941
[TBL] [Abstract][Full Text] [Related]
12. Effects of everolimus in combination with sildenafil in monocrotaline-induced pulmonary hypertension in rats.
Ilgin S; Burukoglu D; Atli O; Sirmagul B
Cardiovasc Toxicol; 2012 Mar; 12(1):46-55. PubMed ID: 21811847
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
[TBL] [Abstract][Full Text] [Related]
14. 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension.
Satoh M; Satoh A
J Pharm Pharm Sci; 2009 Feb; 11(2):118s-130s. PubMed ID: 19203474
[TBL] [Abstract][Full Text] [Related]
15. The beneficial impact of fasudil and sildenafil on monocrotaline-induced pulmonary hypertension in rats: a hemodynamic and biochemical study.
Jasińska-Stroschein M; Owczarek J; Łuczak A; Orszulak-Michalak D
Pharmacology; 2013; 91(3-4):178-84. PubMed ID: 23428587
[TBL] [Abstract][Full Text] [Related]
16. Benzenesulfonamide attenuates monocrotaline-induced pulmonary arterial hypertension in a rat model.
Zapata-Sudo G; Pontes LB; da Silva JS; Lima LM; Nunes IK; Barreiro EJ; Sudo RT
Eur J Pharmacol; 2012 Sep; 690(1-3):176-82. PubMed ID: 22728079
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of vardenafil on pulmonary artery responsiveness in pulmonary hypertension.
Karasu-Minareci E; Ozbudak IH; Ozbilim G; Sadan G
ScientificWorldJournal; 2012; 2012():718279. PubMed ID: 22649315
[TBL] [Abstract][Full Text] [Related]
19. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats.
Schermuly RT; Kreisselmeier KP; Ghofrani HA; Yilmaz H; Butrous G; Ermert L; Ermert M; Weissmann N; Rose F; Guenther A; Walmrath D; Seeger W; Grimminger F
Am J Respir Crit Care Med; 2004 Jan; 169(1):39-45. PubMed ID: 12958054
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil limits monocrotaline-induced pulmonary hypertension in rats through suppression of pulmonary vascular remodeling.
Yen CH; Leu S; Lin YC; Kao YH; Chang LT; Chua S; Fu M; Wu CJ; Sun CK; Yip HK
J Cardiovasc Pharmacol; 2010 Jun; 55(6):574-84. PubMed ID: 20224427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]